«  
  »

Prometheus Launches The First Serogenetic Test To Predict Risk Of Complications From Crohn’s Disease

By roy, on September 1st, 2010

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced the commercial launch of its proprietary PROMETHEUS® Crohn’s Prognostic test…

View full post on Crohn’s / IBD News From Medical News Today

Crohn's disease   , , , , , , , , , ,  
«  
  »

Leave a Reply

 

 

 

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

«  
  »